• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌细胞中肿瘤内皮标志物 8 的过表达可增强肿瘤生长和转移。

Tumor endothelial marker 8 overexpression in breast cancer cells enhances tumor growth and metastasis.

机构信息

Departments of Medical Science, University of Calgary, Alberta, Canada.

出版信息

Cancer Invest. 2011 Dec;29(10):676-82. doi: 10.3109/07357907.2011.626474.

DOI:10.3109/07357907.2011.626474
PMID:22085271
Abstract

Tumor vasculature is known to express high levels of the longest splice variant of tumor endothelial marker 8 (TEM8). Little is known about its expression by tumor cells. Five of eight cell breast cancer cell lines tested expressed significant levels of the longest TEM8 splice variant (TEM8.1), and to a lesser extent, the shortest splice variant (TEM8.3). Breast cancer cell lines expressing high levels of TEM8 are known to be more invasive and typify a more aggressive basal-like phenotype. In vivo studies in the 4T1 murine model showed enhanced tumor growth associated with increased tumor vascularity and metastasis to lymph nodes and lungs. These data suggest that TEM8.1 expression in breast cancer cells confers a more aggressive, proangiogenic phenotype.

摘要

肿瘤血管被认为表达高水平的肿瘤内皮标志物 8(TEM8)的最长剪接变体。关于肿瘤细胞的表达情况知之甚少。在测试的 8 种乳腺癌细胞系中,有 5 种表达了高水平的最长 TEM8 剪接变体(TEM8.1),其次是最短的剪接变体(TEM8.3)。已知表达高水平 TEM8 的乳腺癌细胞系具有更高的侵袭性,代表更具侵袭性的基底样表型。在 4T1 小鼠模型中的体内研究表明,与肿瘤血管生成和淋巴结及肺部转移增加相关的肿瘤生长增强。这些数据表明,乳腺癌细胞中 TEM8.1 的表达赋予了更具侵袭性、促血管生成的表型。

相似文献

1
Tumor endothelial marker 8 overexpression in breast cancer cells enhances tumor growth and metastasis.乳腺癌细胞中肿瘤内皮标志物 8 的过表达可增强肿瘤生长和转移。
Cancer Invest. 2011 Dec;29(10):676-82. doi: 10.3109/07357907.2011.626474.
2
Tumor endothelial marker 8 expression in triple-negative breast cancer.肿瘤内皮标志物 8 在三阴性乳腺癌中的表达。
Anticancer Res. 2011 Oct;31(10):3417-22.
3
Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.CXCR4高表达水平在肿瘤生长、血管生成和转移中的作用。
FASEB J. 2004 Aug;18(11):1240-2. doi: 10.1096/fj.03-0935fje. Epub 2004 Jun 4.
4
Overexpression of the urokinase receptor mRNA splice variant uPAR-del4/5 affects tumor-associated processes of breast cancer cells in vitro and in vivo.尿激酶受体 mRNA 剪接变异体 uPAR-del4/5 的过表达影响乳腺癌细胞在体外和体内的肿瘤相关过程。
Breast Cancer Res Treat. 2011 Jun;127(3):649-57. doi: 10.1007/s10549-010-1042-5. Epub 2010 Jul 16.
5
Antitumor activities of TEM8-Fc: an engineered antibody-like molecule targeting tumor endothelial marker 8.肿瘤内皮标志物8靶向工程化抗体样分子TEM8-Fc的抗肿瘤活性
J Natl Cancer Inst. 2007 Oct 17;99(20):1551-5. doi: 10.1093/jnci/djm132. Epub 2007 Oct 9.
6
Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag.肿瘤内皮标志物8与分化抗原免疫联合可增强肿瘤免疫。
Cytotherapy. 2007;9(1):23-34. doi: 10.1080/14653240601048369.
7
TrkA overexpression enhances growth and metastasis of breast cancer cells.TrkA过表达增强乳腺癌细胞的生长和转移。
Oncogene. 2009 May 7;28(18):1960-70. doi: 10.1038/onc.2009.61. Epub 2009 Mar 30.
8
Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.胰岛素受体底物-2(IRS-2)对人乳腺癌细胞系转移变体中乳腺癌细胞运动性的调节
Oncogene. 2001 Nov 1;20(50):7318-25. doi: 10.1038/sj.onc.1204920.
9
The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.多功能蛋白聚糖G3结构域对局部乳腺癌侵袭和骨转移的影响。
Breast Cancer Res. 2007;9(4):R47. doi: 10.1186/bcr1751.
10
Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.c-erbB-2基因的过表达增强了人乳腺癌细胞的内在转移潜能,而不增加其转化能力。
Cancer Res. 1997 Mar 15;57(6):1199-205.

引用本文的文献

1
Combination strategies with PARP inhibitors in BRCA-mutated triple-negative breast cancer: overcoming resistance mechanisms.PARP抑制剂在BRCA突变三阴性乳腺癌中的联合策略:克服耐药机制
Oncogene. 2025 Feb;44(4):193-207. doi: 10.1038/s41388-024-03227-6. Epub 2024 Nov 21.
2
CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil.嵌合抗原受体 T 细胞疗法在三阴性乳腺癌中的应用:追捕无形的恶魔。
Front Immunol. 2022 Nov 22;13:1018786. doi: 10.3389/fimmu.2022.1018786. eCollection 2022.
3
Targeted silencing of TEM8 suppresses non‑small cell lung cancer tumor growth via the ERK/Bcl‑2 signaling pathway.
靶向沉默 TEM8 通过 ERK/Bcl-2 信号通路抑制非小细胞肺癌肿瘤生长。
Mol Med Rep. 2021 Aug;24(2). doi: 10.3892/mmr.2021.12234. Epub 2021 Jun 24.
4
Latest therapeutic target for gastric cancer: Anthrax toxin receptor 1.胃癌的最新治疗靶点:炭疽毒素受体1。
World J Gastrointest Oncol. 2021 Apr 15;13(4):216-222. doi: 10.4251/wjgo.v13.i4.216.
5
Clinical Value of Detecting Tumor Endothelial Marker 8 (ANTXR1) as a Biomarker in the Diagnosis and Prognosis of Colorectal Cancer.检测肿瘤内皮标志物8(ANTXR1)作为生物标志物在结直肠癌诊断和预后中的临床价值
Cancer Manag Res. 2021 Apr 9;13:3113-3122. doi: 10.2147/CMAR.S298165. eCollection 2021.
6
Converging physiological roles of the anthrax toxin receptors.炭疽毒素受体的趋同生理作用。
F1000Res. 2019 Aug 12;8. doi: 10.12688/f1000research.19423.1. eCollection 2019.
7
The Anthrax Toxin Receptor 1 (ANTXR1) Is Enriched in Pancreatic Cancer Stem Cells Derived from Primary Tumor Cultures.炭疽毒素受体1(ANTXR1)在源自原发性肿瘤培养物的胰腺癌干细胞中富集。
Stem Cells Int. 2019 May 2;2019:1378639. doi: 10.1155/2019/1378639. eCollection 2019.
8
Tumor endothelial marker 8 promotes cancer progression and metastasis.肿瘤内皮标志物8促进癌症进展和转移。
Oncotarget. 2018 Jul 10;9(53):30173-30188. doi: 10.18632/oncotarget.25734.
9
Cryo-Electron Microscopy Structure of Seneca Valley Virus Procapsid.塞尼卡谷病毒衣壳蛋白的冷冻电子显微镜结构。
J Virol. 2018 Feb 26;92(6). doi: 10.1128/JVI.01927-17. Print 2018 Mar 15.
10
TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer.TEM8/ANTXR1 特异性 CAR T 细胞作为三阴性乳腺癌的靶向治疗。
Cancer Res. 2018 Jan 15;78(2):489-500. doi: 10.1158/0008-5472.CAN-16-1911. Epub 2017 Nov 28.